Robert S. Levy

916 total citations
27 papers, 755 citations indexed

About

Robert S. Levy is a scholar working on Molecular Biology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert S. Levy has authored 27 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Psychiatry and Mental health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert S. Levy's work include Bipolar Disorder and Treatment (6 papers), Receptor Mechanisms and Signaling (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Robert S. Levy is often cited by papers focused on Bipolar Disorder and Treatment (6 papers), Receptor Mechanisms and Signaling (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Robert S. Levy collaborates with scholars based in United States. Robert S. Levy's co-authors include Charles Day, Rif S. El‐Mallakh, David G. Changaris, James J. Miller, Mary O. Huff, Sarah Decker, Rena Li, Xiaoping Li, Gregory S. Schultz and R.H. Roth and has published in prestigious journals such as Nature, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Robert S. Levy

27 papers receiving 711 citations

Peers

Robert S. Levy
Fred Baskin United States
J F Dixon United States
P. Fernández‐Vizarra Spain
William K. Sonnenburg United States
Mabel Hokin-Neaverson United States
Annett Häußler Germany
Tom Thomas United States
Anita Wehnert Belgium
Than-Vinh Dam Canada
Michael P. Honchar United States
Fred Baskin United States
Robert S. Levy
Citations per year, relative to Robert S. Levy Robert S. Levy (= 1×) peers Fred Baskin

Countries citing papers authored by Robert S. Levy

Since Specialization
Citations

This map shows the geographic impact of Robert S. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Levy more than expected).

Fields of papers citing papers by Robert S. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Levy. The network helps show where Robert S. Levy may publish in the future.

Co-authorship network of co-authors of Robert S. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Levy. A scholar is included among the top collaborators of Robert S. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Levy. Robert S. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Mallakh, Rif S., et al.. (2006). Efficacy of olanzapine and haloperidol in an animal model of mania. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(7). 1261–1264. 34 indexed citations
2.
El‐Mallakh, Rif S., et al.. (2003). Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disorders. 5(5). 362–365. 101 indexed citations
3.
Decker, Sarah, et al.. (2000). Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(3). 455–462. 46 indexed citations
4.
Levy, Robert S., et al.. (1998). Persistent Hyperactivity Following a Single Intracerebroventricular Dose of Ouabain. Physiology & Behavior. 63(3). 403–406. 48 indexed citations
5.
Li, Rena, et al.. (1997). Lithium prevents ouabain-induced behavioral changes. Molecular and Chemical Neuropathology. 31(1). 65–72. 57 indexed citations
6.
El‐Mallakh, Rif S., et al.. (1995). An animal model for mania: Preliminary results. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19(5). 955–962. 67 indexed citations
7.
Miller, James J., David G. Changaris, & Robert S. Levy. (1992). Purification, subunit structure and inhibitor profile of cathepsin A. Journal of Chromatography A. 627(1-2). 153–162. 8 indexed citations
8.
Miller, James J., David G. Changaris, & Robert S. Levy. (1991). Angiotensin carboxypeptidase activity in urine from normal subjects and patients with kidney damage. Life Sciences. 48(16). 1529–1535. 11 indexed citations
9.
Changaris, David G., Christopher J. H. Porter, James J. Miller, & Robert S. Levy. (1988). Des-Leu angiotensin I: biosynthesis and drinking response. Regulatory Peptides. 20(4). 273–280. 13 indexed citations
10.
Changaris, David G., et al.. (1988). Subcellular Localization in Rat Brain of Angiotensin-Related Carboxypeptidase Activity Distinct from Converting Enzyme. Pathology and Immunopathology Research. 7(3). 200–207. 3 indexed citations
11.
Miller, James J., David G. Changaris, & Robert S. Levy. (1988). Conversion of Angiotensin I to Angiotensin II by cathepsin A isoenzymes of porcine kidney. Biochemical and Biophysical Research Communications. 154(3). 1122–1129. 31 indexed citations
12.
Changaris, David G., James J. Miller, & Robert S. Levy. (1986). Angiotensin II generated by a human renal carboxypeptidase. Biochemical and Biophysical Research Communications. 138(2). 573–579. 20 indexed citations
13.
Day, Charles & Robert S. Levy. (1977). Low Density Lipoproteins. 106 indexed citations
14.
Day, Charles, Richard L. Voet, & Robert S. Levy. (1970). Elimination of low‐density lipoprotein‐polyanion interaction by amino modifications. FEBS Letters. 7(1). 41–43. 7 indexed citations
15.
Day, Charles & Robert S. Levy. (1969). Molecular structure of serum lipoproteins. Journal of Theoretical Biology. 23(3). 387–399. 13 indexed citations
16.
Day, Charles & Robert S. Levy. (1969). Choline-deficiency fatty liver as a consequence of lipoprotein structure. Biochemical Medicine. 3(2). 177–178. 1 indexed citations
17.
Levy, Robert S., et al.. (1967). Amino acid composition of the proteins from chylomicrons and human serum lipoproteins. Journal of Lipid Research. 8(5). 463–472. 37 indexed citations
18.
Roth, R.H., Robert S. Levy, & Nicholas J. Giarman. (1967). Dependence of rat serum lactonase upon calcium. Biochemical Pharmacology. 16(3). 596–598. 27 indexed citations
19.
McConnell, K. P. & Robert S. Levy. (1962). Presence of Selenium-75 in Lipoproteins. Nature. 195(4843). 774–776. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fred Baskin Breakdown of academic impact, for papers by J F Dixon Breakdown of academic impact, for papers by P. Fernández‐Vizarra Breakdown of academic impact, for papers by William K. Sonnenburg Breakdown of academic impact, for papers by Mabel Hokin-Neaverson Breakdown of academic impact, for papers by Annett Häußler Breakdown of academic impact, for papers by Tom Thomas Breakdown of academic impact, for papers by Anita Wehnert Breakdown of academic impact, for papers by Than-Vinh Dam Breakdown of academic impact, for papers by Michael P. Honchar
Rankless by CCL
2026